RESI South

Atlanta Atlanta, GA, United States

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and...

QB3 Webinar: Anna Molofsky, UCSF. “Neuroimmune Regulation of Brain Development and Plasticity”

Online webinar , United States

Synapse remodeling is essential to brain development, learning, and to maintain healthy brain function. Synapses are impacted in many diseases including autism spectrum disorders (ASD), epilepsy, and schizophenia. Brain development depends on the dynamic interactions of multiple cell types, including neurons, astrocytes, and microglia, the immune cells of the brain. Our long term goal is...

BVS’ Biotech Community Event at SOVA Science District, San Diego

We are very excited to announce our outdoor Biotech Community Event at SOVA Science District. Our last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend. This is a special Biotech Community Event sponsored...

Boston Life Sciences Conference

What You'll Learn: How does Boston's biotech ecosystem foster a culture of innovation, and what unique factors contribute to its success? How have significant projects in the area played a role in advancing and shaping the growth and development of the biotech and life science sectors? What role does technology play in meeting tenant expectations...

BIO 2024 Convention Preview & Partnering

Online webinar , United States

The BIO International Convention attracts 15,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Position yourself for success at this year's event, June 3-6, in San Diego! BIO is where business and breakthroughs converge – and the BIO One-on-One Partnering™ system facilitates the connections that fuel...

Halloran Knowledge Hub: Live Webinar – Success Planning for an Original NDA / BLA Submission

Online webinar , United States

Join us for a live webinar on navigating New Drug Applications (NDA) and Biologics License Applications (BLA). Our experts will discuss planning strategies and share insights from recent submissions to empower you in the NDA/BLA journey. Register here! Details: Date: April 4, 2024 Time: 11am EST Duration: 1 Hour (Including a Live Q&A) Audience Key Takeaways: Trigger points for...

The AACR Annual Meeting

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting...

Cell & Gene Meeting on the Med

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated...

From the Innovator’s Workbench featuring Ted W. Love, MD

James H. Clark Auditorium 318 Campus Drive Palo Alto, CA 94305 "I love the capacity to intervene in a situation that could be or is grievous and turn it into something that is extraordinarily positive." In 2014, cardiologist and biotechnology executive Dr. Ted Love, came out of an early retirement for the unique opportunity of...

The GLP-1 Catalyst: Transforming Health Care Markets

The advent of GLP-1 receptor agonists is not just a significant milestone in diabetes and obesity treatment; it presents opportunity for systemic change in disease prevention and management as well as overall health economics. But what does that mean for the health care industry as a whole? Join us for a forward-looking conversation exploring the...